Related Experiment Videos
Achalasia in pregnancy.
Victoria Khudyak1, Joseph Lysy, David Mankuta
1Hadassah University Hospital, Jerusalem, Israel.
Obstetrical & Gynecological Survey
|February 24, 2006
Summary
Achalasia, a rare esophageal motility disorder, impacts swallowing and causes chest pain. Limited data exists on its effects during pregnancy, necessitating further research into management strategies.
Area of Science:
- Gastroenterology
- Esophageal Motility Disorders
- Clinical Management
Background:
- Achalasia is a rare esophageal motor disorder characterized by impaired lower esophageal sphincter relaxation and absent esophageal peristalsis.
- The condition results from the loss of intramural neurons, affecting individuals of all ages and genders.
- Key symptoms include dysphagia, chest pain, and regurgitation.
Purpose of the Study:
- To review the limited available information on the effects of achalasia on pregnancy outcomes.
- To explore how pregnancy may influence the natural course of achalasia.
- To consolidate current understanding and identify knowledge gaps regarding achalasia in pregnancy.
Main Methods:
- Literature review of published studies and case reports focusing on achalasia and pregnancy.
- Synthesis of data from two small studies (totaling 30 patients) and case series.
- Analysis of reported symptoms, treatment outcomes, and potential interactions between achalasia and pregnancy.
Main Results:
- Existing literature on achalasia in pregnancy is scarce, primarily consisting of case reports and limited studies.
- Information regarding the impact of achalasia on pregnancy outcomes is not well-established.
- The effects of pregnancy on the progression or management of achalasia remain largely uncharacterized.
Conclusions:
- There is a significant lack of comprehensive data on achalasia management and outcomes during pregnancy.
- Further research, including larger cohort studies, is crucial to understand and guide the care of pregnant patients with achalasia.
- Current treatment options for achalasia, such as nitrates, calcium channel blockers, botulinum toxin, pneumatic dilation, and esophagomyotomy, require careful consideration in pregnant individuals.